Target type: biologicalprocess
Any process that increases the rate, frequency, or extent of the progression of the sclerotome over time, from its initial formation to the mature structure. The sclerotome is the portion of the somite that will give rise to a vertebra. [GOC:BHF, GOC:dph]
Positive regulation of sclerotome development is a complex process that involves a series of molecular and cellular events that control the formation of the sclerotome, which is the portion of the somite that gives rise to the vertebral column. The sclerotome is derived from the ventral portion of the somite, and its development is tightly regulated by a network of signaling pathways, transcription factors, and extracellular matrix components.
One of the key signaling pathways involved in sclerotome development is the Wnt pathway. Wnt signaling is activated by a family of secreted glycoproteins that bind to Frizzled receptors on the cell surface. Wnt signaling promotes the expression of genes that are essential for sclerotome formation, such as Pax1 and Pax9. These transcription factors are essential for the specification of the sclerotome and the expression of other genes involved in vertebral column development.
Another important signaling pathway involved in sclerotome development is the Shh pathway. Shh is a secreted protein that plays a critical role in the patterning of the somite and the development of the vertebral column. Shh signaling is activated by binding to the Patched receptor on the cell surface. Shh signaling promotes the expression of genes that are essential for sclerotome differentiation, such as Gli1 and Gli3. These transcription factors are essential for the expression of genes involved in cartilage formation and the development of the intervertebral discs.
The sclerotome is also influenced by the surrounding environment. The notochord, which lies ventral to the somite, secretes factors that promote sclerotome formation. These factors include Shh and Noggin, which inhibit the activity of bone morphogenetic proteins (BMPs) that would otherwise promote the formation of the dermomyotome, another portion of the somite.
The development of the sclerotome is further regulated by the extracellular matrix (ECM). The ECM is a complex network of proteins and carbohydrates that surrounds and supports cells. The ECM provides structural support and plays a role in cell signaling and migration. During sclerotome development, the ECM undergoes significant changes in composition and organization. This remodeling of the ECM is essential for the migration and differentiation of sclerotome cells.
In summary, positive regulation of sclerotome development involves a complex interplay of signaling pathways, transcription factors, and ECM components. These factors work together to control the specification, differentiation, and migration of sclerotome cells, ultimately leading to the formation of the vertebral column.'
"
Protein | Definition | Taxonomy |
---|---|---|
Sonic hedgehog protein | A sonic hedgehog protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q15465] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
jervine | jervine: teratogen from Veratrum grandiflorum; RN given refers to parent cpd(3beta,23beta)-isomer; structure | piperidines | |
cyclopamine | piperidines | glioma-associated oncogene inhibitor | |
cur 61414 | CUR 61414: inhibits the hedehog signaling pathway; structure in first source | ||
gdc 0449 | HhAntag691: inhibits the hedgehog pathway and ABC transporters; has antineoplastic activity | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent |
robotnikinin | robotnikinin: binds sonic hedgehog protein to block its signaling pathway; structure in first source |